MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).
| Outcome | beta | se | p | method | nSNP | cis/trans | coloc |
|---|---|---|---|---|---|---|---|
| LDL cholesterol | -0.184 | 0.0282 | 7.03e-11 | Wald ratio | 1 | trans | 0.988 |
| Total cholesterol | -0.115 | 0.027 | 2.27e-05 | Wald ratio | 1 | trans | NA |
| Triglycerides | -0.0999 | 0.0259 | 1.16e-04 | Wald ratio | 1 | trans | NA |
| Diagnoses - main ICD10: L03 Cellulitis | 0.00251 | 0.000842 | 0.00289 | Inverse variance weighted | 2 | cis | NA |
| Diagnoses - main ICD10: L03 Cellulitis | 0.00251 | 0.000842 | 0.00289 | Inverse variance weighted | 2 | trans | NA |
| Depressive symptoms | -0.0473 | 0.0168 | 0.00488 | Inverse variance weighted | 2 | cis | NA |
| Depressive symptoms | -0.0473 | 0.0168 | 0.00488 | Inverse variance weighted | 2 | trans | NA |
| Chronic kidney disease | 0.158 | 0.059 | 0.0073 | Inverse variance weighted | 2 | cis | NA |
| Chronic kidney disease | 0.158 | 0.059 | 0.0073 | Inverse variance weighted | 2 | trans | NA |
| Diagnoses - main ICD10: H25 Senile cataract | 0.002 | 0.000824 | 0.0149 | Inverse variance weighted | 2 | cis | NA |
| Diagnoses - main ICD10: H25 Senile cataract | 0.002 | 0.000824 | 0.0149 | Inverse variance weighted | 2 | trans | NA |
| HDL cholesterol | 0.0642 | 0.0267 | 0.016 | Wald ratio | 1 | trans | NA |
| …and 153 more outcomes (see JSON) |
No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).
1 association rows across 1 traits (1 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.
| Trait | best p | lead SNP | n assoc | study | MR status |
|---|---|---|---|---|---|
| Standing height (UKB data field 50) | 3e-12 | rs112473448 | 1 | GCST90468178 | no MR -> candidate analysis |
Top diseases by Open Targets association (of 110 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.
| Disease | genetic assoc. | burden (ExWAS) | causal status | MR status |
|---|---|---|---|---|
| undetermined early-onset epileptic encephalopathy | 0.438 | — | established (curated) | no MR -> candidate analysis |
| developmental and epileptic encephalopathy, 33 | 0.438 | — | established (curated) | no MR -> candidate analysis |
| aortic disorder | 0.419 | — | common-variant locus | no MR -> candidate analysis |
| Dermatochalasis | 0.318 | — | common-variant locus | no MR -> candidate analysis |
| skin aging | 0.245 | — | common-variant locus | no MR -> candidate analysis |
| COVID-19 | 0.206 | — | common-variant locus | no MR -> candidate analysis |
| Abnormality of the skeletal system | 0.164 | — | common-variant locus | no MR -> candidate analysis |
| osteoarthritis | 0.102 | — | common-variant locus | no MR -> candidate analysis |
Of the 8 rows above, 8 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.
| Layer | Result |
|---|---|
| ChEMBL druggability | not available — no ChEMBL target (undrugged) |
| gnomAD constraint | pLI=0.0005, LOEUF=0.954 — LoF-tolerant |
| GWAS Catalog | 55 unique SNPs / 110 rows |
| ClinVar | 133 records; 2 pathogenic in sample of 30 |
| PharmGKB/ClinPGx | no annotations |
phenome — Top 30 of 110 associated diseases by overall score. genetic_association aggregates GWAS common-variant AND rare-variant evidence. These are ASSOCIATIONS (loci), not causal claims.chembl — No ChEMBL target for ‘ISLR2’.clinvar — Pathogenic count is over the 30 record(s) retrieved, NOT over all 133 ClinVar records for this gene; it is a sample, not a rate.pharmgkb — No PharmGKB/ClinPGx clinical annotations (gene may not be a pharmacogene).gwas_traits — Top 1 of 1 traits by best p-value, aggregated from 1 association rows. These are GWAS ASSOCIATIONS (loci), not causal claims; mapped genes at a locus are not necessarily the effector gene.uniprot: https://www.uniprot.org/uniprotkb/Q6UXK2 — UniProt release 2026_02 (10-June-2026)mr_outcomes: https://epigraphdb.org/pqtl/ — EpiGraphDB pQTL MR (Zheng et al., Nat Genet 2020) — pre-computed two-sample MR; retrieved, not computed by this agent; EpiGraphDB build 1.0, pQTL dataset v3.0phenome: https://platform.opentargets.org/target/ENSG00000167178/associations — Open Targets data release 26.06gnomad: https://gnomad.broadinstitute.org/gene/ISLR2 — gnomAD constraint via GraphQL API (reference genome GRCh38)gwas: https://www.ebi.ac.uk/gwas/genes/ISLR2 — GWAS Catalog REST (live; release not exposed by this endpoint)clinvar: https://www.ncbi.nlm.nih.gov/clinvar/?term=ISLR2%5Bgene%5D — ClinVar build Build260809-1055.1gwas_traits: https://www.ebi.ac.uk/gwas/genes/ISLR2 — GWAS Catalog search API (live; release not exposed)